erosive esophagitis sucralfate cimetidine influence pretreatment esophageal sphincter pressure serum pepsinogen levels Forty-eight patients erosive reflux esophagitis sucralfate tablets g/day cimetidine g/day weeks randomized prospective single-blind cross-over therapeutic trial Pretreatment esophageal sphincter LES pressure serum pepsinogen PG-I levels possible predictors drug trial patients sucralfate group cimetidine group patient group side effects Symptom improvement similar extent groups Endoscopic results weeks treatment sucralfate complete healing esophageal erosions cimetidine improvement additional cimetidine differences significant patients drug healing esophagitis drug crossover LES pressure outcome patients sucralfate patients refractory LES pressure mm Hg good response -receptor blockade Patients esophagitis sucralfate serum PG-I levels treatment failure ng/mL vs ng/mL opposite patients cimetidine ng/mL responders ng/mL nonresponders results sucralfate valuable alternative inhibitors treatment reflux esophagitis preliminary evidence LES pressures PG-I levels predictive value response drugs 